Agency for evolving and promotion of STEM disciplines

'Ideal biomarker' detects Alzheimer's disease before the onset of symptoms

A new biomarker detects Alzheimer's disease in its preclinical phase, identifying individuals with impaired neuropsychological and neurophysiological functions. The discovery has high accuracy and sensitivity, offering a promising approach to early diagnosis and treatment.